American Century Companies’s NovoCure NVCR Stock Holding History

American Century Companies’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.17M	Sell	198,738 -842,794	-81%	-$10.5M	﹤0.01%	2087
2025 Q4	$13.5M	Sell	1,041,532 -177,275	-15%	-$2.28M	0.01%	1323
2025 Q3	$15.7M	Buy	1,218,807 +188,933	+18%	+$2.52M	0.01%	1245
2025 Q2	$18.3M	Buy	1,029,874 +959,079	+1,355%	+$16.7M	0.01%	1134
2025 Q1	$1.26M	Buy	+70,795	New	+$1.61M	﹤0.01%	2174
2023 Q2	–	Sell	-14,770	Closed	-$888K	–	2825
2023 Q1	$888K	Buy	14,770 +3,966	+37%	+$317K	﹤0.01%	1907
2022 Q4	$792K	Sell	10,804 -2,670	-20%	-$201K	﹤0.01%	1881
2022 Q3	$1.02M	Buy	13,474 +2,347	+21%	+$183K	﹤0.01%	1681
2022 Q2	$773K	Buy	11,127 +6,377	+134%	+$480K	﹤0.01%	1748
2022 Q1	$393K	Buy	4,750 +3	+0.1%	+$221	﹤0.01%	2038
2021 Q4	$356K	Hold	4,747	–	–	﹤0.01%	2058
2021 Q3	$551K	Sell	4,747 -5,376	-53%	-$813K	﹤0.01%	1845
2021 Q2	$2.25M	Sell	10,123 -1,812	-15%	-$352K	﹤0.01%	1219
2021 Q1	$1.58M	Sell	11,935 -28,940	-71%	-$4.58M	﹤0.01%	1253
2020 Q4	$7.07M	Buy	40,875 +24,211	+145%	+$3.31M	0.01%	825
2020 Q3	$1.85M	Sell	16,664 -11,620	-41%	-$929K	﹤0.01%	989
2020 Q2	$1.68M	Sell	28,284 -22,085	-44%	-$1.45M	﹤0.01%	961
2020 Q1	$3.39M	Buy	+50,369	New	+$3.98M	﹤0.01%	777

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

American Century Companies's NVCR Position: Q1 2026 in Review

American Century Companies reduced its NovoCure (NVCR) stake by 81% in Q1 2026, selling an estimated $10.5M and leaving 198,738 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2087.

American Century Companies first reported a position in NVCR in Q1 2020 and has held it in 18 quarters since. The position peaked at $18.3M in Q2 2025. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

American Century Companies held 198,738 shares of NovoCure worth $2.17M as of Q1 2026.
American Century Companies sold 842,794 NovoCure shares in Q1 2026, an estimated $10.5M.
NovoCure made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2087 holding.
American Century Companies first reported a position in NovoCure in Q1 2020 and has held it in 18 quarters since.
American Century Companies's NovoCure position peaked at $18.3M in Q2 2025.
223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.